Daiichi Sankyo Drug Said To Equal Warfarin, Better For Sicker Patients
This article was originally published in PharmAsia News
Executive Summary
A large clinical trial has shown Daiichi Sankyo's DU-176b (endoxaban) anticlotting drug to as effective as warfarin and causes less bleeding in venous thromboembolism, the company revealed at an international conference.